Sort
141,003 grants matching “cytokine”
Meditation and Exercise for Prevention of Acute Respiratory Infection
$726,891Bruce P Barrett · University Of Wisconsin-Madison · R01 · FY2009 · AT
Dual drug delivery to lung/blood interface in respiratory infections.
$726,891Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2022 · HL
Building on the success of the adoptive immunotherapy of cancer
$726,880Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
The role of adverse social-biological interactions in acute myeloid leukemia disparities
$726,828Irum Khan · Northwestern University At Chicago · R01 · FY2025 · CA
Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer
$726,788Meghan E. Sise · Massachusetts General Hospital · R01 · FY2022 · DK
T cells in the aging brain
$726,768Anne Brunet · Stanford University · R01 · FY2024 · AG
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$726,766Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2018 · CA
New Paradigms in Gene Regulation During Influenza Virus Infections
$726,683Curt M Horvath · Northwestern University · U01 · FY2011 · AI
Functional outcomes of inflammatory bowel disease associated variants
$726,682Clara Abraham · Yale University · R01 · FY2023 · DK
Genetic Markers of Long-Term Mumps Vaccine Immunity
$726,665Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2017 · AI
Functional impact of IL33 polymorphisms on asthma & other Th2-mediated diseases
$726,656Kathleen C Barnes · Johns Hopkins University · R01 · FY2014 · HL
Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer
$726,628Meghan E. Sise · Massachusetts General Hospital · R01 · FY2023 · DK
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$726,511David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Advancing the development of a novel class of small molecules for treating pan-coronavirus infections
$726,503Shirit Einav · Stanford University · R01 · FY2024 · AI
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2
$726,465Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Modeling intra- and inter-cellular networks for TRPC6-dependent cardiac fibrosis
$726,452Jeffrey J. Saucerman · University Of Virginia · R01 · FY2025 · HL
ISLET-KIDNEY TRANSPLANTATION FOR TYPE I DIABETES
$726,436University Of California Los Angeles · R01 · FY2000 · DK
Alleviation of chemotherapy-induced cardiovascular toxicity
$726,408Yanbo Fan · University Of Cincinnati · R01 · FY2024 · HL
Role of Inflammation in SCD-related Pain in Children with Sickle Cell Disease
$726,346Robin E Miller · Nemours Children'S Hospital, Delaware · P20 · FY2016 · GM
Deciphering Molecular Mechanisms of Post-Stroke Depression in Aged Mice
$726,328Venugopal Reddy Venna · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AG
Pro-inflammatory activation of human macrophages regulated by lncRNAs
$726,322Masanori Aikawa · Brigham And Women'S Hospital · R01 · FY2020 · HL
GENETIC, IMMUNOLOGIC AND MECHANISTIC BASIS OF HUMAN NK CELL DEFICIENCY
$726,302Jordan Scott Orange · Baylor College Of Medicine · R01 · FY2016 · AI
Innate immune response of LTBI+HIV+ children
$726,289Ramakrishna Vankayalapati · Saint Louis University · R01 · FY2024 · AI
EPSTEIN BARR VIRUS LMP1 MEDIATED ONCOGENICITY
$726,269Brigham And Women'S Hospital · R01 · FY2004 · CA
Evaluating the role of P53 pathways in malaria
$726,260Tuan Manh Tran · Indiana University Indianapolis · R01 · FY2024 · AI